SCHEMBL5177560

SCHEMBL5177560

O=C(O)c1ccc2[nH]c(-c3ccc(Cc4ccc(Cl)s4)cc3)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 10/20 0.51
▸ PRSS12 P56730 1/20 0.50
▸ NR4A2 P43354 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SCD O00767 3/20 0.45
▸ MPL P40238 1/20 0.44
▸ MMP2 P08253 1/20 0.44
▸ MMP9 P14780 1/20 0.44
▸ MMP8 P22894 1/20 0.44
▸ MMP13 P45452 1/20 0.44
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3561228 0.91 CHEK2 (0.61) CHEK2KMT2A
SCHEMBL3571326 0.84 CHEK2 (0.67) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL5177752 0.82 CHEK2 (0.45) CHEK2PRSS12KMT2ASCD
SCHEMBL28930292 0.80 KDM4E (0.68) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL3567770 0.80 CHEK2 (0.66) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL11563729 0.79 CHEK2 (0.78) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL7602620 0.79 KDM4E (0.70) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL3863014 0.78 CSNK2A2 (0.49) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL3918744 0.78 CHEK2 (0.80) CHEK2NR4A2KDM4EALDH1A1HPGD
SCHEMBL3568288 0.78 CHEK2 (0.72) CHEK2NR4A2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613313-B1 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-4,5]-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2007-06-06 — — EP claimed
Send feedback